InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Clowes Howard, Director. Director active across 1 company, notably Plus Therapeutics, INC.. Aggregated, 7 disclosures have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €54k. Activity tracked since 2 June 2022. The latest transaction was disclosed on 11 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
7 of 7 declarations
Howard Clowes is a Board Member at PLUS THERAPEUTICS, INC. He brings expertise in business management and growth strategies. His role as a board member involves overseeing the company's operations and contributing to strategic decision-making. Howard is committed to ensuring compliance and promoting best governance practices within the organization.